万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://acsjournals.onlinelibrary.wiley.com/journal/19346638
3、投稿网址：
http://mc.manuscriptcentral.com/cancercyto
4、官网邮箱：cancercyto@cancer.org（编辑部）
5、官网电话：(404) 327-6411（编辑部）
6、期刊刊期：月刊，一年出版12期。
2022年1月11日星期二
投稿须知【官网信息】
CANCER CYTOPATHOLOGY Author Guidelines
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Authors can post their results in clinical trial registries or submit them to government regulatory agencies without the manuscript being considered previously published or an overlapping publication. Cancer Cytopathology will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/cancercyto.
Click here for more details on how to use ScholarOne Manuscripts.
For help with submissions, please contact: cancercyto@cancer.org
2. AIMS AND SCOPE
Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.
AMERICAN CANCER SOCIETY MISSION
The American Cancer Society is the nationwide community based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer through research, education, advocacy, and service.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Manuscripts must be submitted to Cancer Cytopathology via ScholarOne Manuscripts. Please contact the Cancer Cytopathology Editorial Office at (404) 327-6411 or cancercyto@cancer.org if you have any questions about submitting your manuscript online.
Papers that exceed the length limitations as described in this guide will not be considered for review.
Original Articles: Scientific reports of the results of original clinical research. The text is limited to 6000 words including the title page, abstract, text, references, and tables. Abstracts are limited to 250 words.
Review Articles: A timely, in-depth treatment of an issue. Review articles are generally solicited by the editors, but unsolicited materials will be considered. Review articles must be no longer than 8000 words including title page, abstract, text, tables, and references.
Editorials: Opinions of recognized leaders in oncologic specialties. Editorials are generally solicited by the Editor-in-Chief and are related to a manuscript in the same issue. Length should not exceed 2400 words with no more than 20 references.
Commentaries: Presents a point of view of general interest not related to an article in the same issue of Cancer Cytopathology.
Tributes: Highlights the accomplishments of distinguished individuals for their contributions to oncology.
Correspondence: Letters to the Editor related to papers previously published in Cancer Cytopathology. Letters must be submitted within three months of the online publication date of the article discussed in order to be considered. The authors of the original publication will be given the opportunity to respond in the same issue of Cancer Cytopathology. Letters and responses must not exceed 400 words in length, must be limited to three authors and five references, and should not have tables or figures. Financial associations or other potential conflicts of interest must be disclosed.
Case reports of single cases will not be considered.
……
更多详情：
https://acsjournals.onlinelibrary.wiley.com/hub/journal/19346638/homepage/forauthors.html
